CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...